Half-year report · Q2
9993.TEDINET S100UIY9
Period2024-03-01 → 2024-08-31
Filed2024-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥51.0bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥101.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.6bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Operating income | −¥682m | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥532m | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | −¥275m | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥677m | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥570m | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Profit before tax | −¥275m | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥587m | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥451m | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.1bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥58.3bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥58.2bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥56.0bn | at 2023-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.7bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥29.3bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥27.7bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥28.9bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥29.5bn | at 2023-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.1bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2023-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4.0bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.6bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥177m | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-97.99 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.92 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.89 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥95.06 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.4% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.6% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-03-01 → 2024-08-31 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-03-01 → 2024-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-03-01 → 2024-08-31 | −¥165m |
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-08-31 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-08-31 | −¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-08-31 | ¥4m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥6.4bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥6.4bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2024-03-01 → 2024-08-31 | −¥127m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥44.8bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥44.5bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥292m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2024-03-01 → 2024-08-31 | −¥394m |
| —segment total | revenue | 2024-03-01 → 2024-08-31 | ¥51.2bn |
| —segment total | revenue external | 2024-03-01 → 2024-08-31 | ¥51.0bn |
| —segment total | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥292m |
| —segment total | segment profit | 2024-03-01 → 2024-08-31 | −¥521m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-03-01 → 2024-08-31 | ¥53.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-03-01 → 2024-08-31 | ¥51.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-03-01 → 2024-08-31 | −¥687m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-03-01 → 2023-08-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-03-01 → 2023-08-31 | ¥78m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-08-31 | ¥5m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥36m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥44.5bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥44.2bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥412m |
| —segment total | revenue | 2023-03-01 → 2023-08-31 | ¥50.9bn |
| —segment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| —segment total | segment profit | 2023-03-01 → 2023-08-31 | ¥449m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-08-31 | ¥53.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-08-31 | ¥527m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 44156000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 6489000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 50646000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 50650000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 50650000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 297000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 297000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2187000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2485000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2485000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 44454000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 6489000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 50943000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2192000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 53135000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2485000000 | JPY |
| Net sales | Prior1YTDDuration | 50650000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 412000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 36000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 449000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 78000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 527000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 5000000 | JPY |
| Operating income | Prior1YTDDuration | 532000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 44509000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 6445000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 50954000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 50958000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 50958000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 292000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 292000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2529000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2822000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -2822000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | 44801000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E03228-000DrugstoreBusinessReportableSegmentsMember | 6445000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 51247000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2533000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 53780000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -2822000000 | JPY |
| Net sales | CurrentYTDDuration | 50958000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E03228-000SupermarketBusinessReportableSegmentsMember | -394000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |